Skip to main content
Moss Genomics Inc. logo

Moss Genomics Inc. — Investor Relations & Filings

Ticker · MOSS ISIN · CA61965T1012 LEI · 529900DZ4CWNHUPHGZ02 CSE Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country CA Canada
Listing CSE MOSS

About Moss Genomics Inc.

https://mossgenomics.com/

Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research, dedicated to developing advanced genetic insights and personalized health solutions. The company's core offering is a blockchain-based platform designed for the private, secure storage and monetization of individual genomic data. Recent corporate strategy has emphasized significant integration with digital assets, positioning the company as a hybrid entity. This strategy includes substantial investments in Ethereum (ETH) and participation in cryptocurrency mining operations, such as Bitcoin Cash (BCH), alongside its consumer genomics initiatives.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a certification form (Form 52-109FV2) attesting to the interim financial report and MD&A for the period ended December 31, 2024. It is not the interim report itself (so it’s not an IR filing) nor an announcement of publication of a report. Instead, it’s a regulatory compliance filing (a certificate under NI 52-109). It therefore best fits the general “Regulatory Filings” category (RNS).
2025-03-03 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is a standalone Management’s Discussion and Analysis (MD&A) for the period ended December 31, 2024, providing management’s interpretation of financial condition, results of operations, risks and forward‐looking statements. It is not a brief announcement nor an earnings press release, but rather a detailed management report accompanying interim financial statements. This directly matches the definition of a Management Report (Code: MDA).
2025-03-03 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive set of 'Condensed Consolidated Interim Financial Statements' for Moss Genomics Inc. for the period ended December 31, 2024. It includes the Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, Statement of Cash Flow, and detailed Notes to the Financial Statements. It is not an announcement or a summary, but the full interim financial report itself, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-03-03 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing changes in the Board of Directors and senior management (new Director and CFO appointments, departures of previous officers). This clearly fits the definition of a Board/Management Information filing.
2025-02-26 English
Material change report - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a Canadian securities “Material Change Report” (Form 51-102F3) announcing the closing of a non-brokered private placement (2.5 million shares at C$0.10) and issuance of new common shares for the acquisition of 160 ETH, i.e., new share issues and related capital structure changes. While it also notes a director appointment, the primary focus is the financing and share issuance. This fits “Share Issue/Capital Change” (SHA) rather than a general earnings release or annual report.
2025-02-11 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing the closing of a non-brokered private placement for gross proceeds of $250,000 and an equity-for-ETH acquisition, which constitutes a financing and capital structure change. While it also notes the appointment of a new board director, the primary focus is on the fundraising transaction. This fits the Capital/Financing Update category (CAP).
2025-02-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.